News
Shortcuts from other journals
Antibodies to myelin don't predict progression to multiple sclerosis
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7587.231-a (Published 01 February 2007) Cite this as: BMJ 2007;334:231
It's hard to predict what will happen to patients who present with a first neurological episode suggestive of multiple sclerosis. Some will recover, whereas others will progress to the full blown clinical disease. An accurate prognostic test would be a real benefit to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.